Compare SPXC & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPXC | CAI |
|---|---|---|
| Founded | 1912 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.1B | 8.0B |
| IPO Year | N/A | 2025 |
| Metric | SPXC | CAI |
|---|---|---|
| Price | $208.01 | $25.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $214.14 | $34.71 |
| AVG Volume (30 Days) | 826.4K | ★ 2.0M |
| Earning Date | 02-24-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 26.00 | N/A |
| EPS | ★ 4.69 | N/A |
| Revenue | ★ $2,161,500,000.00 | $649,062,000.00 |
| Revenue This Year | $16.13 | $77.57 |
| Revenue Next Year | $8.81 | $35.22 |
| P/E Ratio | $44.28 | ★ N/A |
| Revenue Growth | 12.60 | ★ 112.02 |
| 52 Week Low | $115.00 | $22.86 |
| 52 Week High | $233.71 | $42.50 |
| Indicator | SPXC | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 50.06 | N/A |
| Support Level | $189.37 | N/A |
| Resistance Level | $212.79 | N/A |
| Average True Range (ATR) | 5.99 | 0.00 |
| MACD | 0.10 | 0.00 |
| Stochastic Oscillator | 79.61 | 0.00 |
SPX Technologies Inc supplies engineered heating, ventilation, and air conditioning, or HVAC, products, as well as detection and measurement technologies and power equipment. The company through two reportable segments. The HVAC segment which generates the majority of the revenue for the company, designs, manufactures, installs, and services cooling products, as well as heating and ventilation products. The detection and measurement technologies segment designs, manufactures, and installs underground pipe and cable locators and inspection equipment, bus-fare collection systems, and others. Geographically, the company has its operations in the United States, Canada, China, the United Kingdom, and Others.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.